CyberKnife Center of Chicago is proud to commemorate the 20th anniversary of CyberKnife® technology this year. Developed in 1994 at Stanford by Dr. John Adler, the concept was conceived with the goal of treating tumors throughout the body with radiosurgery, a treatment that at the time was restricted to head and neck tumors. The prototype system developed by Dr. Adler was used from 1994 to 2001.
The U.S. Food and Drug Administration approved the CyberKnife in 2001 and the technology has been adopted internationally for the treatment of primary and metastatic tumors throughout the body.
CyberKnife manufacturer, Accuray, reports that the system has been used in 40 countries to treat more than half a million patients to date.
Over the last two decades, CyberKnife has evolved as a treatment method with expanded applications and the availability of long-term patient results to further demonstrate its efficacy. Most recently the American Society for Radiation Oncology endorsed CyberKnife as a first line treatment option for prostate cancer.
Since opening in 2009, CyberKnife Center of Chicago has been a proud provider of CyberKnife treatment. Lung tumors, brain tumors and prostate cancer are among our center’s most frequently treated diseases.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.